Lantern Pharma Files 10-Q for Q1 2025
Ticker: LTRN · Form: 10-Q · Filed: May 15, 2025 · CIK: 1763950
| Field | Detail |
|---|---|
| Company | Lantern Pharma Inc. (LTRN) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceutical, financials
TL;DR
Lantern Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Lantern Pharma Inc. filed its 10-Q for the period ending March 31, 2025, reporting on its financial performance and business operations. The company, incorporated in Texas, is involved in the pharmaceutical preparations industry. Key financial data and business addresses in Dallas, TX, are detailed in the filing.
Why It Matters
This filing provides investors and stakeholders with an update on Lantern Pharma's financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Lantern Pharma faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the financial period covered by the report.)
- 20250515 — Filing Date (Shows when the report was officially submitted to the SEC.)
Key Players & Entities
- Lantern Pharma Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- Dallas, TX (location) — Company's business and mailing address
- 1920 MCKINNEY AVENUE (address) — Company's business and mailing address
FAQ
What is the primary business of Lantern Pharma Inc. according to the filing?
Lantern Pharma Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
For which fiscal period is this 10-Q report filed?
This 10-Q report is filed for the period ending March 31, 2025.
Where is Lantern Pharma Inc. headquartered?
Lantern Pharma Inc.'s business and mailing addresses are located in Dallas, TX.
What is the SEC file number for Lantern Pharma Inc.?
The SEC file number for Lantern Pharma Inc. is 001-39318.
When was the company's name last changed?
The company's name was last changed on January 8, 2019.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Lantern Pharma Inc. (LTRN).